Insider Selling: Forty Seven Inc (NASDAQ:FTSV) Insider Sells $91,643.04 in Stock

Share on StockTwits

Forty Seven Inc (NASDAQ:FTSV) insider Mark Anthony Mccamish sold 8,301 shares of the stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $11.04, for a total value of $91,643.04. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Mark Anthony Mccamish also recently made the following trade(s):

  • On Monday, May 20th, Mark Anthony Mccamish sold 16,500 shares of Forty Seven stock. The shares were sold at an average price of $12.10, for a total value of $199,650.00.
  • On Thursday, April 18th, Mark Anthony Mccamish sold 16,500 shares of Forty Seven stock. The shares were sold at an average price of $18.12, for a total value of $298,980.00.

FTSV opened at $10.84 on Thursday. The stock’s 50 day moving average is $12.48. Forty Seven Inc has a 1 year low of $9.90 and a 1 year high of $23.83.

Forty Seven (NASDAQ:FTSV) last posted its quarterly earnings results on Monday, May 13th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.14). On average, analysts predict that Forty Seven Inc will post -2.72 earnings per share for the current year.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. grew its position in Forty Seven by 89.5% during the 4th quarter. BlackRock Inc. now owns 845,954 shares of the company’s stock worth $13,298,000 after acquiring an additional 399,591 shares during the last quarter. JPMorgan Chase & Co. grew its position in Forty Seven by 51.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 346,066 shares of the company’s stock worth $5,164,000 after acquiring an additional 117,142 shares during the last quarter. Vanguard Group Inc. grew its position in Forty Seven by 144.4% during the 3rd quarter. Vanguard Group Inc. now owns 171,060 shares of the company’s stock worth $2,553,000 after acquiring an additional 101,060 shares during the last quarter. Candriam Luxembourg S.C.A. grew its position in Forty Seven by 500.0% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 120,000 shares of the company’s stock worth $1,939,000 after acquiring an additional 100,000 shares during the last quarter. Finally, Northern Trust Corp grew its position in Forty Seven by 388.3% during the 4th quarter. Northern Trust Corp now owns 88,769 shares of the company’s stock worth $1,396,000 after acquiring an additional 70,591 shares during the last quarter. Institutional investors and hedge funds own 47.34% of the company’s stock.

Several equities analysts have recently commented on FTSV shares. Oppenheimer reiterated a “buy” rating on shares of Forty Seven in a research report on Tuesday, March 19th. HC Wainwright reiterated a “buy” rating and set a $21.00 price objective on shares of Forty Seven in a research report on Friday, March 29th. Zacks Investment Research upgraded Forty Seven from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a research report on Tuesday, April 2nd. Guggenheim started coverage on Forty Seven in a research report on Friday, April 12th. They set a “buy” rating on the stock. Finally, Roth Capital started coverage on Forty Seven in a research report on Wednesday, May 29th. They set a “buy” rating and a $28.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Forty Seven currently has an average rating of “Buy” and a consensus target price of $26.89.

About Forty Seven

Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody.

Read More: Economic Reports

Insider Buying and Selling by Quarter for Forty Seven (NASDAQ:FTSV)

Receive News & Ratings for Forty Seven Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forty Seven and related companies with MarketBeat.com's FREE daily email newsletter.